A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers

Background: The recommended booster third dose of vaccination against COVID-19 in cancer patients seems reasonable to protect them against a severe disease course. A prospective study was designed to assess the immunogenicity, efficacy, and safety of COVID-19 vaccination in this cohort. Methods: Pat...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	Urska Janzic, Urska Bidovec-Stojkovic, Peter Korosec, Katja Mohorcic, Loredana Mrak, Marina Caks, Maja Ravnik, Erik Skof, Matija Rijavec
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Subjects:	solid cancer COVID-19 vaccination booster third dose immunogenicity
Online Access:	https://www.mdpi.com/2076-393X/11/6/1017